Cargando…

Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1

Microvascular injury, oxidative stress, and impaired angiogenesis are prominent features of systemic sclerosis (SSc). We compared serum markers of these phenomena at baseline and after treatment with nifedipine in SSc patients. Forty successive SSc patients were compared with 20 matched healthy subj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Allanore, Yannick, Borderie, Didier, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC464873/ https://www.ncbi.nlm.nih.gov/pubmed/15225366 http://dx.doi.org/10.1186/ar1183

Ejemplares similares

Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis
por: Allanore, Yannick, et al.
Publicado: (2005)

Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites
por: Jakimovska, Marina, et al.
Publicado: (2014)

High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence
por: Jakimovska, Marina, et al.
Publicado: (2020)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

The clinical usefulness of assessing the concentration of cell adhesion molecules sVCAM-1 and sICAM-1 in the serum of women with primary breast cancer
por: Thielemann, Anna, et al.
Publicado: (2014)

Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Elevated in Bronchoalveolar Lavage Fluid of Patients with Acute Respiratory Distress Syndrome
por: Attia, Engi F., et al.
Publicado: (2016)

Upregulation of sICAM-1 and sVCAM-1 Levels in the Cerebrospinal Fluid of Patients with Schizophrenia Spectrum Disorders
por: Meixensberger, Sophie, et al.
Publicado: (2021)

Dietary Antioxidants Decrease Serum Soluble Adhesion Molecule (sVCAM-1, sICAM-1) but not Chemokine (JE/MCP-1, KC) Concentrations, and Reduce Atherosclerosis in C57BL but Not ApoE*3 Leiden Mice Fed an Atherogenic Diet
por: Murphy, Nuala, et al.
Publicado: (2005)

Circulating Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Associated With Left Atrial Remodeling in Long-Distance Runners
por: Contreras-Briceño, Felipe, et al.
Publicado: (2021)

Flaxseed Prevents Leukocyte and Platelet Adhesion to Endothelial Cells in Experimental Atherosclerosis by Reducing sVCAM-1 and vWF
por: Haliga, Raluca Ecaterina, et al.
Publicado: (2013)

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis
por: Hamzaoui, A., et al.
Publicado: (1996)

Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients
por: Vilas-Boas, Wendell, et al.
Publicado: (2010)

Elevated circulating vascular cell Adhesion Molecule-1 (sVCAM-1) is associated with concurrent depressive symptoms and cerebral white matter Hyperintensities in older adults
por: Tchalla, Achille E., et al.
Publicado: (2015)

Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen
por: Cowan, Robert P., et al.
Publicado: (2021)

TNF-α Inhibitors in Combination with MTX Reduce Circulating Levels of Heparan Sulfate/Heparin and Endothelial Dysfunction Biomarkers (sVCAM-1, MCP-1, MMP-9 and ADMA) in Women with Rheumatoid Arthritis
por: Szeremeta, Anna, et al.
Publicado: (2022)

A Comparative Study of Serum Level of Vascular Cell Adhesion Molecule-1 (sVCAM-1), Intercellular Adhesion Molecule-1(ICAM-1) and High Sensitive C - reactive protein (hs-CRP) in Normal and Pre-eclamptic Pregnancies
por: Farzadnia, Mehdi, et al.
Publicado: (2013)

Elevation of serum soluble E-selectin and VCAM-1 in severe asthma.
por: Hamzaoui, A, et al.
Publicado: (2001)

Shenmai-Yin decreased the clearance of nifedipine in rats: The involvement of time-dependent inhibition of nifedipine oxidation
por: Wang, Hong-Jaan, et al.
Publicado: (2018)

Soluble form of ICAM-1, VCAM-1, E- and L-selectin in human milk.
por: Xyni, K, et al.
Publicado: (2000)

Nifedipine–pyrazine (2/1)
por: Schultheiss, Nate, et al.
Publicado: (2010)

Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
por: Frantz, Camelia, et al.
Publicado: (2018)

A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine
por: Bi, Ye, et al.
Publicado: (2020)

Preoperative soluble VCAM‐1 contributes to predict late mortality after coronary artery surgery
por: Corbalan, Ramon, et al.
Publicado: (2020)

Kinetics and prognostic value of soluble VCAM‐1 in ST‐segment elevation myocardial infarction patients
por: Hayek, Ahmad, et al.
Publicado: (2021)

Protein cross‐linking and the Maillard reaction decrease the solubility of milk protein concentrates
por: Fan, Fengjiao, et al.
Publicado: (2018)

High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders
por: Vizcardo-Galindo, Gustavo, et al.
Publicado: (2020)

Increased Serum Oxidative Stress Markers in Women with Uterine Leiomyoma
por: Santulli, Pietro, et al.
Publicado: (2013)

Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study
por: Nowak, Jan K., et al.
Publicado: (2017)

Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis
por: Gasparin, Andrese Aline, et al.
Publicado: (2020)

Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer
por: Takahashi, Ryota, et al.
Publicado: (2020)

Decreased serum concentrations of sphingosine-1-phosphate in sepsis
por: Winkler, Martin Sebastian, et al.
Publicado: (2015)

Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM)
por: Grabmaier, U., et al.
Publicado: (2016)

Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies
por: Ta, Duy Tien, et al.
Publicado: (2016)

Serum Concentrations of Soluble Flt-1 Are Decreased among Women with a Viable Fetus and No Symptoms of Miscarriage Destined for Pregnancy Loss
por: Kaitu'u-Lino, Tu'uhevaha J., et al.
Publicado: (2012)

Nifedipine Treatment Reduces Resting Calcium Concentration, Oxidative and Apoptotic Gene Expression, and Improves Muscle Function in Dystrophic mdx Mice
por: Altamirano, Francisco, et al.
Publicado: (2013)

Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia
por: Martínez-Jiménez, Cecilia, et al.
Publicado: (2018)

IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts
por: Tamby, Mathieu C, et al.
Publicado: (2008)

VCAM-1 targeted alpha-particle therapy for early brain metastases
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2020)

ICAM-1 Clustering on Endothelial Cells Recruits VCAM-1
por: van Buul, Jaap D., et al.
Publicado: (2010)

VCAM1 and ICAM1 expression in oral lichen planus
por: Seyedmajidi, Maryam, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h992oa4tdetn1kl1tjqe0d0d9h